BACKGROUND AND AIMS: Endoscopic treatment is effective in the treatment of patients with bile duct injury after cholecystectomy. We aimed to investigate the long-term results of endoscopic treatment, factors predicting the recurrence of the stricture, and to determine the optimal endoscopic treatment. METHODS: The study was a retrospective cohort analysis and conducted at a tertiary referral center in patients with major bile duct injury (Strasberg E1-4 and E5 patients with main bile duct injury). Patients with minor injury (Luschka and cystic duct leakage), complete transection, and isolated aberrant bile duct injuries were excluded. RESULTS: The study group included 156 patients. The median follow-up period after stent removal was 6.5 years (range 1-16.5). Recurrence was seen in 18 patients (11 %) after a median duration of 9 months (range 2-96). Multivariate regression analysis revealed that the most important factors predicting the success of endoscopic treatment were: Rome type of treatment (inserting increasing number of stents every 3-4 months) (odds ratio 23.8, 95 % CI 1.46-390.7, p = 0.026) instead of Amsterdam-type treatment (replacing two 10F biliary stents every 3-4 months) and dilation of the stricture diameter to at least 76 % of the common bile duct diameter at the end of stent treatment (odds ratio 25.9, 95 % CI 2.46-272.7, p = 0.007). CONCLUSIONS: Endoscopic treatment is an effective method in the treatment of patients with bile duct stricture after cholecystectomy. Inserting multiple stents as much as possible without leaving a scar in the bile ducts should be aimed.
BACKGROUND AND AIMS: Endoscopic treatment is effective in the treatment of patients with bile duct injury after cholecystectomy. We aimed to investigate the long-term results of endoscopic treatment, factors predicting the recurrence of the stricture, and to determine the optimal endoscopic treatment. METHODS: The study was a retrospective cohort analysis and conducted at a tertiary referral center in patients with major bile duct injury (Strasberg E1-4 and E5 patients with main bile duct injury). Patients with minor injury (Luschka and cystic duct leakage), complete transection, and isolated aberrant bile duct injuries were excluded. RESULTS: The study group included 156 patients. The median follow-up period after stent removal was 6.5 years (range 1-16.5). Recurrence was seen in 18 patients (11 %) after a median duration of 9 months (range 2-96). Multivariate regression analysis revealed that the most important factors predicting the success of endoscopic treatment were: Rome type of treatment (inserting increasing number of stents every 3-4 months) (odds ratio 23.8, 95 % CI 1.46-390.7, p = 0.026) instead of Amsterdam-type treatment (replacing two 10F biliary stents every 3-4 months) and dilation of the stricture diameter to at least 76 % of the common bile duct diameter at the end of stent treatment (odds ratio 25.9, 95 % CI 2.46-272.7, p = 0.007). CONCLUSIONS: Endoscopic treatment is an effective method in the treatment of patients with bile duct stricture after cholecystectomy. Inserting multiple stents as much as possible without leaving a scar in the bile ducts should be aimed.
Authors: J J Bergman; L Burgemeister; M J Bruno; E A Rauws; D J Gouma; G N Tytgat; K Huibregtse Journal: Gastrointest Endosc Date: 2001-08 Impact factor: 9.427
Authors: N Tuvignon; C Liguory; T Ponchon; B Meduri; J Fritsch; J Sahel; J Boyer; J L Legoux; J Escourrou; C Boustiere; J P Arpurt; M Barthet; P Tuvignon; G Bommelaer; B Ducot; F Prat Journal: Endoscopy Date: 2011-03-01 Impact factor: 10.093
Authors: Jason K Sicklick; Melissa S Camp; Keith D Lillemoe; Genevieve B Melton; Charles J Yeo; Kurtis A Campbell; Mark A Talamini; Henry A Pitt; JoAnn Coleman; Patricia A Sauter; John L Cameron Journal: Ann Surg Date: 2005-05 Impact factor: 12.969
Authors: Gary C Vitale; Tin C Tran; Brian R Davis; Michael Vitale; David Vitale; Gerald Larson Journal: J Am Coll Surg Date: 2008-05 Impact factor: 6.113